Tianda Pharmaceuticals Limited announced consolidated earnings results for the year ended March 31, 2021. For the year, the company reported revenue of HKD 474,332,111 as compared to HKD 491,475,099 a year ago. Loss for the period was HKD 25,917,806 as compared to profit for the period of HKD 8,800,206 a year ago. Basic and diluted loss per share attributable to ordinary equity holders of the company was 1.26 cents as compared basic and diluted earnings per share attributable to ordinary equity holders of the company to 0.15 cents a year ago.